Forecast & Rating4 analysts currently cover Inmune Bio, of which 4 give a positive rating. The average price target is $7.00, about 186.9% upside from the current price of $2.44. Coverage is limited, so the data is for reference only. Data as of Aug 26, 2026; this does not constitute investment advice.
Aug 26, 2026Price forecast
$7.00186.89%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 31, 2026
Forecast met6.9%
Stock price$2.44
Avg. target$5.3
High target$8
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.